iRadimed Corporation (NASDAQ:IRMD - Get Free Report) shares crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $56.56 and traded as high as $62.07. iRadimed shares last traded at $59.02, with a volume of 57,917 shares.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen upgraded shares of iRadimed from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, May 6th.
Get Our Latest Research Report on iRadimed
iRadimed Stock Performance
The business's 50 day moving average is $56.68 and its 200-day moving average is $55.59. The firm has a market capitalization of $750.56 million, a price-to-earnings ratio of 38.07 and a beta of 0.91.
iRadimed Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were issued a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $0.68 dividend on an annualized basis and a yield of 1.15%. iRadimed's payout ratio is 43.87%.
Hedge Funds Weigh In On iRadimed
A number of institutional investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. grew its stake in iRadimed by 78.7% in the 1st quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock valued at $27,000 after buying an additional 226 shares during the last quarter. US Bancorp DE lifted its holdings in shares of iRadimed by 476.6% during the 4th quarter. US Bancorp DE now owns 617 shares of the medical equipment provider's stock worth $34,000 after acquiring an additional 510 shares during the period. Quantbot Technologies LP bought a new stake in shares of iRadimed during the 1st quarter worth approximately $78,000. Huntington National Bank lifted its holdings in shares of iRadimed by 34.0% during the 4th quarter. Huntington National Bank now owns 1,993 shares of the medical equipment provider's stock worth $110,000 after acquiring an additional 506 shares during the period. Finally, Comerica Bank lifted its holdings in shares of iRadimed by 21.4% during the 1st quarter. Comerica Bank now owns 2,288 shares of the medical equipment provider's stock worth $120,000 after acquiring an additional 404 shares during the period. 92.34% of the stock is currently owned by institutional investors and hedge funds.
iRadimed Company Profile
(
Get Free Report)
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Further Reading
Before you consider iRadimed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRadimed wasn't on the list.
While iRadimed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
